Search results
Results from the WOW.Com Content Network
Abbreviations are used very frequently in medicine. They boost efficiency as long as they are used intelligently. The advantages of brevity should be weighed against the possibilities of obfuscation (making the communication harder for others to understand) and ambiguity (having more than one possible interpretation).
This is a list of abbreviations used in medical prescriptions, including hospital orders (the patient-directed part of which is referred to as sig codes). This list does not include abbreviations for pharmaceuticals or drug name suffixes such as CD, CR, ER, XT (See Time release technology ยง List of abbreviations for those).
Stedman's Medical Dictionary is a medical dictionary developed for medical students, physicians, researchers, and medical language specialists. Entries include medical terms, abbreviations, acronyms, measurements, and more. Pronunciation and word etymology (showing mostly Latin and Greek prefixes and roots) are provided with most definitions.
The main discussion of these abbreviations in the context of drug prescriptions and other medical prescriptions is at List of abbreviations used in medical prescriptions. Some of these abbreviations are best not used, as marked and explained here.
The Systematized Nomenclature of Medicine ( SNOMED) is a systematic, computer-processable collection of medical terms, in human and veterinary medicine, to provide codes, terms, synonyms and definitions which cover anatomy, diseases, findings, procedures, microorganisms, substances, etc. It allows a consistent way to index, store, retrieve, and ...
Fanconi anemia. FAMMM syndrome. familial atypical multiple mole melanoma syndrome. FANA. fluorescent antinuclear antibody test. FAP. familial adenomatous polyposis. FAST. focused assessment with sonography for trauma.
The Physicians' Desk Reference was first published in 1947 by Medical Economics Inc., a magazine publisher founded by Lansing Chapman. [2] Medical Economics Inc. merged with Reinhold Publishing in 1966 to form Chapman-Reinhold. [3] Litton Industries, which owned the American Book Company, acquired Chapman-Reinhold in 1968. [4]
In January 2023, the US Food and Drug Administration (FDA) approved zanubrutinib for chronic lymphocytic leukemia or small lymphocytic lymphoma. [19] In March 2024, FDA granted accelerated approval to zanubrutinib, in combination with obinutuzumab , for relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.